Company Overview and News
Action camera company GoPro (NASDAQ:GPRO) unveiled its lineup of new products on Thursday, launching just ahead of this year’s all-important holiday shopping season. GoPro stock rallied a bit because, well, at least a small faction of investors rev up their bullishness whenever the company makes any sort of move.
GPRO FB FIT SNAP
Growth stocks have led the market for a long time, but last week we saw many interest rate-sensitive value stocks (like insurance companies and utilities) firm up. This temporary rotation into value stocks is a bit odd, since the 10-year Treasury bond yield rose decisively above the 3% level, despite low inflation.
FIT MU WEED AAPL CGC TLRY
2018-09-25 investorplace - 1
Roku (NASDAQ:ROKU) has been on a winning streak this summer. In just a few months, ROKU stock is up more than 50%. Previously, Roku had seen more sideways trading as investors and analysts considered various pros and cons affecting the company.
SONO GPRO FIT AMZN ROKU NFLX DIS
Fitbit, Inc. (FIT - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $5.45–$6.29 in the past one-month time frame, witnessed a sharp increase yesterday.
FIT KEYS SIR HAYN LB
Health insurer Humana Inc. (HUM - Free Report) has extended its partnership (since 2013) with Fitbit, Inc. (FIT - Free Report) , the leading global wearables brand. The arrangement between the two companies will aid Humana’s members in the employer group segment to adopt and implement healthy behaviors, which in turn would prevent and manage chronic health conditions. Fitbit’s health coaching solution named Fitbit Care, will help more than 5 million Humana members access ways to make necessary lifestyle changes in order to better manage chronic and complex diseases such as diabetes and heart disease.
ATHTF FIT CI ANTM LB HUM ANTX
The trade war between the U.S. and China continues to escalate, with Beijing set to impose tariffs on $60 billion in U.S. imports in response to the Trump administrations’ new set of tariffs on $200 billion in Chinese imports. Despite the mounting pressure on companies in the world’s two largest economies, some firms and their products appear to be safe.
FB FIT SPWR UNP NFLX GOOGL AAPL MSFT GM INTC
The Wall Street has shown immense strength, shrugging of escalating trade war concerns between the United States and China. All the three major large-cap indices were up at least 0.5% on Sep 18 with Dow Jones logging in the best day in about three weeks. This suggests strong complacency in the stock market backed by booming economy and strong corporate earnings. A slew of upbeat economic data indicates a healthier economy.
FNDX FIT UNP AAPL DIA VYM SPYV
Wall Street closed sharply higher on Tuesday reversing the previous day’s losses as investors shrugged off trade war jitters. Elimination of nearly 300 important items from the list of Chinese products which were targeted by the Trump administration in the last round of tariffs along with a measured response on the part of China lifted confidence of market participants. Consequently, a broad-based market rally enabled all here major stock indexes to finish in positive territory.
FIT CATR CAT BOE AAPL BA
The holiday season is approaching and retailers are set to hire seasonal workers. Per Deloitte’s annual forecast for the holiday season, retail sales could top $1.10 trillion this year. With record low unemployment, higher wages and strong consumer confidence, an increasing number of Americans are willing to spend more.
MOV FIT SUMR TLYS AAPL ZUMZ MOVAA BOOT
Fitbit Inc. on Wednesday announced its new Fitbit Care platform, part of the company’s broader efforts to entice more health-care players and generate recurring revenue.
Chicago, IL – September 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apple, Inc. (AAPL - Free Report) , Fitbit, Inc. (FIT - Free Report) , Cisco Systems, Inc. (CSCO - Free Report) , Qualcomm, Inc. (QCOM - Free Report) and Micron Technology, Inc.
RYAM FIT ESE ON CVTI UNFI SWKS DVMT MU GTS AAPL CSCO MS QCOM INT CSCOI TSC
Wall Street shrugged off early losses on Sep 18 to close in the green as investors chose to ignore trade tensions. Stocks moved north after the latest tariffs from the United States and China were less harmful than expected.
FIT DSW CBPX USY AAPL UFPT RCII UIS
2017-10-11 - Asif
Fitbit's mission is to help people lead healthier, more active lives by empowering them with data, inspiration, and guidance to reach their goals. Fitbit is transforming the way millions of people around the world achieve their health and fitness goals. The Fitbit platform combines wearable devices with connected health solutions via software and services, including an online dashboard and mobile apps, data analytics, motivational and social tools, personalized insights, and virtual coaching through customized fitness plans and interactive workouts. Its platform helps people become more active, exercise more, sleep better, eat smarter, and manage their weight. Fitbit appeals to a large, mainstream health and fitness market by addressing these key needs with advanced technology embedded in simple-to-use products and services. The company pioneered the wearable device market starting in 2007, and since then, The company have grown into a leading global health and fitness brand. Fi...
19h - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
as of ET